中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

胰腺癌的影像学诊断及术前可切除性和分期的影像学评估

陈璐 余日胜

引用本文:
Citation:

胰腺癌的影像学诊断及术前可切除性和分期的影像学评估

DOI: 10.3969/j.issn.1001-5256.2016.12.015
基金项目: 

基金项目:浙江省胰腺癌综合诊治科技创新团队(2013TD06); 

详细信息
  • 中图分类号: R735.9;R730.44;R445.2

Imaging diagnosis of pancreatic cancer and preoperative imaging evaluation of resectability and staging

Research funding: 

 

  • 摘要: 胰腺癌是一种高病死率的侵袭性恶性肿瘤。多层螺旋CT血管成像作为首选的胰腺成像手段,可评判胰周主要血管是否受侵、受侵范围和程度,为肿瘤分期、手术可切除性评估等提供可靠依据。MRI为CT的一种重要补充检查手段,对疾病诊断、肝转移和预后评估有重要的指导价值。胰腺癌血管侵犯情况是术前评估胰腺癌是否可切除的主要指标。淋巴结转移、远处转移、胰腺癌周围神经受侵及肝动脉变异等因素均会影响患者预后。指出胰腺癌患者的术前影像学评估对治疗方案制订、术式选择及预后判断具有指导意义。

     

  • [1]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2016[J].CA Cancer J Clin,2016,66(1):7-30.
    [2]RAHIB L,SMITH BD,AIZENBERG R,et al.Projecting cancer incidence and deaths to 2030:the unexpected burden of thyroid,liver,and pancreas cancers in the United States[J].Cancer Res,2014,74(11):2913-2921.
    [3]BONOMI A,SORDI V,DUGNANI E,et al.Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells[J].Cytotherapy,2015,17(12):1687-1695.
    [4]KLAASSEN R,BENNINK RJ,van TIENHOVEN G,et al.Feasibility and repeatability of PET with the hypoxia tracer[(18)F]HX4 in oesophageal and pancreatic cancer[J].Radiother Oncol,2015,116(1):94-99.
    [5]MACARI M,SPIELER B,KIM D,et al.Dual-source dual-energy MDCT of pancreatic adenocarcinoma:initial observations with data generated at 80 k Vp and at simulated weighted-average 120k Vp[J].AJR Am J Roentgenol,2010,194(1):w27-w32.
    [6]YU SP,XIN J,XU WN,et al.Analysis of 18F-FDG PET/CT and enhanced CT in evaluation of resectability of pancreatic cancer[J].J Mod Oncol,2012,20(6):1221-1224.(in Chinese)于树鹏,辛军,徐微娜,等.18F-FDG PET/CT与增强CT对胰腺癌可切除性评估价值分析[J].现代肿瘤医学,2012,20(6):1221-1224.
    [7]Group of Pancreas Surgery,Chinese Society of Surgery,Chinese Medical Association.Guidelines for the management of pancreatic cancer(2014)[J].J Clin Hepatol,2014,30(12):1240-1245.(in Chinese)中华医学会外科学分会胰腺外科学组.胰腺癌诊治指南(2014)[J].临床肝胆病杂志,2014,30(12):1240-1245.
    [8]KITAHASHI T,MUTOH M,TSURUSAKI M,et al.Imaging study of pancreatic ductal adenocarcinomas in Syrian hamsters using X-ray micro-computed tomography(CT)[J].Cancer Science,2010,101(7):1761-1766.
    [9]KAWADA N,UEHARA H,KATAYAMA K,et al.Diagnostic clues and subsequent examinations that detected small pancreatic cancer[J].Hepatogastroenterology,2012,59(118):1665-1669.
    [10]PARK MJ,KIM YK,CHOI SY,et al.Preoperative detection of small pancreatic carcinoma:value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level[J].Radiology,2014,273(2):433-443.
    [11]MASTORAKI A,CHATZIMAVRIDOU-GRIGORIADOU V,CHATZIPETROU V,et al.Familial pancreatic cancer:challenging diagnostic approach and therapeutic management[J].J Gastrointest Cancer,2014,45(3):256-261.
    [12]AL-HAWARY MM,FRANCIS IR,CHARI ST,et al.Pancreatic ductal adenocarcinoma radiology reporting template:consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association[J].Radiology,2014,270(1):248-260.
    [13]SIEGEL R,MA J,ZOU Z,et al.Cancer statistics,2014[J].CA Cancer J Clin,2014,64(1):9-29.
    [14]LOYER EM,DAVID CL,DUBROW RA,et al.Vascular involvement in pancreatic adenocarcinoma:reassessment by thin-section CT[J].Abdom Imaging,1996,21(3):202-206.
    [15]LU DS,REBER HA,KRASNY RM,et al.Local staging of pancreatic cancer:criteria for unresectability of major vessels as revealed by pancreatic-phase,thin-section helical CT[J].AJR Am J Roentgenol,1997,168(6):1439-1443.
    [16]NAKAYAMA Y,YAMASHITA Y,KADOTA M,et al.Vascular encasement by pancreatic cancer:correlation of CT findings with surgical and pathologic results[J].J Comput Assist Tomogr,2001,25(3):337-342.
    [17]BUCHS NC,CHILCOTT M,POLETTI PA,et al.Vascular invasion in pancreatic cancer:imaging modalities,preoperative diagnosis and surgical management[J].World J Gastroenterol,2010,16(7):818-831.
    [18]YIN YJ,ZENG MS,LI H,et al.Pancreatic carcinoma invasion to peripancreatic vessels:evaluation the resectability with MRI[J].J Clin Radiol,2005,24(9):792-795.(in Chinese)殷允娟,曾蒙苏,李卉,等.MRI对胰腺癌胰周血管侵犯的手术可切除性评价[J].临床放射学杂志,2005,24(9):792-795.
    [19]LI H,ZENG MS,ZHOU KR,et al.The CT signs of peripancreatic vascular invasion in pancreatic carcinoma[J].Chin J Radiol,2005,39(3):293-297.(in Chinese)李卉,曾蒙苏,周康荣,等.胰腺癌侵犯胰周主要血管的CT表现分析[J].中华放射学杂志,2005,39(3):293-297.
    [20]LI XB,TIAN JM,WANG PJ,et al.Dual-phases angiography of pancreas with multi-slice helical CT[J].Chin J Med Imaging Technol,2002,18(5):428-430.(in Chinese)李晓兵,田建明,王培军,等.多层螺旋CT胰腺双期血管成像研究[J].中国医学影像技术,2002,18(5):428-430.
    [21]LI MS,MENG FQ.The reasons of underestimating the extent of pancreatic cancer invasion of peripancreatic vessels through imaging[J].J Pract Radiol,2016,32(1):45-47,55.(in Chinese)李明山,孟凡琴.胰周血管受胰腺癌侵犯程度常被影像学低估的原因分析[J].实用放射学杂志,2016,32(1):45-47,55.
    [22]ASSIFI MM,LU X,EIBL G,et al.Neoadjuvant therapy in pancreatic adenocarcinoma:a meta-analysis of phase II trials[J].Surgery,2011,150(3):466-473.
    [23]CASSINOTTO C,MOURIES A,LAFOURCADE JP,et al.Locally advanced pancreatic adenocarcinoma:reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy[J].Radiology,2014,273(1):108-116.
    [24]KATZ MH,FLEMING JB,BHOSALE P,et al.Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators[J].Cancer,2012,118(23):5749-5756.
    [25]FERRONE CR,MARCHEGIANI G,HONG TS,et al.Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer[J].Ann Surg,2015,261(1):12-17.
    [26]XIAO Z,LUO G,LIU C,et al.Molecular mechanism underlying lymphatic metastasis in pancreatic cancer[J].Biomed Res Int,2014,2014:925845.
    [27]LIU ZQ,XIAO ZW,LUO GP,et al.Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma[J].Hepatobiliary Pancreat Dis Int,2014,13(6):634-641.
    [28]PAI RK,BECK AH,MITCHEM J,et al.Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma:direct lymph node invasion has similar survival to node-negative disease[J].Am J Surg Pathol,2011,35(2):228-234.
    [29]LUO GP,NI QX,YU XJ.Clinical application value of lymph node ratio in pancreatic cancer[J].Chin J Dig Surg,2015,14(8):686-688.(in Chinese)罗国培,倪泉兴,虞先濬.胰腺癌中淋巴结转移率的临床应用价值[J].中华消化外科杂志,2015,14(8):686-688.
    [30]MACK MG,RIEGER J,BAGHI M,et al.Cervical lymph nodes[J].Eur J Radiol,2008,66(3):493-500.
    [31]KING AD,TSE GM,AHUJA AT,et al.Necrosis in metastatic neck nodes:diagnostic accuracy of CT,MR imaging,and US[J].Radiology,2004,230(3):720-726.
    [32]FONG ZV,TAN WP,LAVU H,et al.Preoperative imaging for resectable periampullary cancer:clinicopathologic implications of reported radiographic findings[J].J Gastrointest Surg,2013,17(6):1098-1106.
    [33]WANG L,LIU LH,HAN C,et al.A comparative study of computed tomography and magnetic resonance imaging in pathological diagnosis of regional lymph node metastasis[J].Chin J Radiat Oncol,2015,24(5):493-496.(in Chinese)王澜,刘丽虹,韩春,等.依据CT及MRI确定区域淋巴结转移的病理对照研究[J].中华放射肿瘤学杂志,2015,24(5):493-496.
    [34]LOW G,PANU A,MILLO N,et al.Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas[J].Radiographics,2011,31(4):993-1015.
    [35]MOTOSUGI U,ICHIKAWA T,MORISAKA H,et al.Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging:comparison with contrast-enhanced multidetector row CT[J].Radiology,2011,260(2):446-453.
    [36]LEE KH,LEE JM,PARK JH,et al.MR imaging in patients with suspected liver metastases:value of liver-specific contrast agent gadoxetic acid[J].Korean J Radiol,2013,14(6):894-904.
    [37]DAI H,LI R,WHEELER T,et al.Enhanced survival in perineural invasion of pancreatic cancer:an in vitro approach[J].Hum Pathol,2007,38(2):299-307.
    [38]DESHMUKH SD,WILLMANN JK,JEFFREY RB.Pathways of extrapancreatic perineural invasion by pancreatic adenocarcinoma:evaluation with 3D volume-rendered MDCT imaging[J].AJR Am J Roentgenol,2010,194(3):668-674.
    [39]MOCHIZUKI K,GABATA T,KOZAKA K,et al.MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma:correlation with en bloc pathological specimens and diagnostic accuracy[J].Eur Radiol,2010,20(7):1757-1767.
    [40]ZUO HD,TANG W,ZHANG XM,et al.CT and MR imaging patterns for pancreatic carcinoma invading the extrapancreatic neural plexus(Part II):imaging of pancreatic carcinoma nerve invasion[J].World J Radiol,2012,4(1):13-20.
    [41]HAYANO K,MIURA F,AMANO H,et al.Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients[J].J Hepatobiliary Pancreat Sci,2013,20(2):243-248.
    [42]SHUKLA PJ,BARRETO SG,KULKARNI A,et al.Vascular anomalies encountered during pancreatoduodenectomy:do they influence outcomes?[J].Ann Surg Oncol,2010,17(1):186-193.
    [43]MICHELS NA.Newer anatomy of the liver and its variant blood supply and collateral circulation[J].Am J Surg,1966,112(3):337-347.
    [44]LU C,LIU ZQ.The imaging study of hepatic arterial variations[J].Chin J Interv Imaging Ther,2006,3(2):84-87.(in Chinese)卢川,刘作勤.肝动脉解剖变异影像学研究[J].中国介入影像与治疗学,2006,3(2):84-87.
  • 加载中
计量
  • 文章访问数:  2255
  • HTML全文浏览量:  17
  • PDF下载量:  436
  • 被引次数: 0
出版历程
  • 出版日期:  2016-12-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回